肥胖合并糖尿病前期的中医病机与中医药干预研究进展
Research Progress on Traditional Chinese Medicine Pathogenesis and Interventions for Obesity with Prediabetes
DOI: 10.12677/tcm.2026.1510600, PDF,   
作者: 毛 宁*:黑龙江中医药大学第一临床医学院,黑龙江 哈尔滨;马 建#:黑龙江中医药大学附属第一医院内分泌科,黑龙江 哈尔滨
关键词: 肥胖;糖尿病前期;中医病机;中医药干预;胰岛素抵抗;Obesity; Prediabetes; Traditional Chinese Medicine Pathogenesis; Chinese Medicine Intervention; Insulin Resistance
摘要: 肥胖与糖尿病前期均为2型糖尿病(type 2 diabetes mellitus, T2DM)的重要危险因素,二者常合并存在并互为因果,显著增加T2DM及心血管代谢疾病的发生风险。糖尿病前期属于血糖调节受损阶段,具有一定可逆性,是预防T2DM的关键窗口期。中医学认为,肥胖合并糖尿病前期多归属于“脾瘅”“痰湿”“肥满”等范畴,其核心病机为脾失健运、痰湿膏脂内蕴,兼夹郁热、气阴不足及血瘀,以健脾化痰、祛湿泄浊为基本治法。近年来,中药复方、中成药及针刺、电针、穴位埋线等中医特色疗法在改善该人群体重、糖脂代谢及胰岛素抵抗方面积累了较多临床证据,其作用机制涉及改善胰岛素抵抗、调节脂肪组织炎症及维持糖脂代谢稳态等多条途径。本文系统综述肥胖合并糖尿病前期的中西医认识与中医药干预研究进展,指出现有研究在诊断界定、证候评价及研究设计等方面仍存不足,以期为该人群的中西医结合防治及后续高质量研究提供参考。
Abstract: Obesity and prediabetes are both important risk factors for type 2 diabetes mellitus (T2DM), and their co-occurrence significantly increases the risk of progression to T2DM and cardiometabolic diseases. Prediabetes is a reversible stage of impaired glucose regulation and represents a critical window for diabetes prevention. In traditional Chinese medicine (TCM), obesity complicated with prediabetes is mostly classified under the categories of “pi dan” (spleen-dampness), phlegm-dampness and obesity (fei man). Its core pathogenesis is summarized as deficiency of the spleen in transportation and transformation as the root, with internal accumulation of phlegm-dampness and turbid lipid as the branch, frequently accompanied by stagnant heat, deficiency of qi and yin, and blood stasis; the basic therapeutic principle is invigorating the spleen to resolve phlegm and dispelling dampness to eliminate turbidity. In recent years, accumulating clinical evidence has shown that Chinese herbal formulae, Chinese patent medicines and acupuncture-related therapies, including manual acupuncture, electroacupuncture and acupoint catgut embedding, may improve body weight, glucose and lipid metabolism and insulin resistance in this population. The underlying mechanisms may involve improving insulin resistance, modulating adipose tissue inflammation and maintaining glucose-lipid metabolic homeostasis. This review summarizes the modern medical and TCM understanding of obesity complicated with prediabetes and the research progress of TCM interventions, and points out remaining deficiencies in diagnostic definition, syndrome evaluation and study design, so as to provide a reference for integrative prevention and further high-quality research.
文章引用:毛宁, 马建. 肥胖合并糖尿病前期的中医病机与中医药干预研究进展[J]. 中医学, 2026, 15(10): 644-652. https://doi.org/10.12677/tcm.2026.1510600

参考文献

[1] 国家卫生健康委员会. 中国居民营养与慢性病状况报告(2020年)[EB/OL].
https://www.nhc.gov.cn/xcs/c100122/202012/175301a949ce481a9c1a9a2b393c8e49.shtml, 2021-12-23.
[2] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[3] Xu, Y., Wang, L., He, J., et al. (2013) Prevalence and Control of Diabetes in Chinese Adults. JAMA, 310, 948-959.
https://doi.org/10.1001/jama.2013.168118
[4] Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., et al. (2017) Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 317, 2515-2523.
https://doi.org/10.1001/jama.2017.7596
[5] 中华医学会内分泌学分会, 中华医学会糖尿病学分会, 等. 中国成人糖尿病前期干预的专家共识[J]. 中华内分泌代谢杂志, 2020, 36(5): 371-380.
[6] Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. (2002) Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England Journal of Medicine, 346, 393-403.
[7] Pan, X.R., Li, G.W., Hu, Y.H., Wang, J., Yang, W., An, Z., et al. (1997) Effects of Diet and Exercise in Preventing NIDDM in People with Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care, 20, 537-544.
https://doi.org/10.2337/diacare.20.4.537
[8] Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A. and Laakso, M. (2002) Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomised Trial. The Lancet, 359, 2072-2077.
https://doi.org/10.1016/s0140-6736(02)08905-5
[9] 国家卫生和计划生育委员会. WS/T 428-2013成人体重判定[S]. 北京: 中国标准出版社, 2013.
[10] Kahn, S.E., Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms Linking Obesity to Insulin Resistance and Type 2 Diabetes. Nature, 444, 840-846.
https://doi.org/10.1038/nature05482
[11] Hotamisligil, G.S. (2017) Inflammation, Metaflammation and Immunometabolic Disorders. Nature, 542, 177-185.
https://doi.org/10.1038/nature21363
[12] 田代华. 黄帝内经素问[M]. 北京: 人民卫生出版社, 2005.
[13] 周仲瑛. 中医内科学[M]. 第2版. 北京: 中国中医药出版社, 2007.
[14] 仝小林. 糖络杂病论[M]. 北京: 科学出版社, 2010.
[15] 朱震亨. 格致余论[M]. 北京: 人民卫生出版社, 2005.
[16] 李杲. 脾胃论[M]. 北京: 人民卫生出版社, 2005.
[17] 王琦. 中医体质学[M]. 北京: 人民卫生出版社, 2009.
[18] Tian, J., Jin, D., Bao, Q., Ding, Q., Zhang, H., Gao, Z., et al. (2019) Evidence and Potential Mechanisms of Traditional Chinese Medicine for the Treatment of Type 2 Diabetes: A Systematic Review and Meta‐Analysis. Diabetes, Obesity and Metabolism, 21, 1801-1816.
https://doi.org/10.1111/dom.13760
[19] Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., et al. (2008) Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine. The Journal of Clinical Endocrinology & Metabolism, 93, 2559-2565.
https://doi.org/10.1210/jc.2007-2404
[20] Panigrahi, A. and Mohanty, S. (2023) Efficacy and Safety of HIMABERB® Berberine on Glycemic Control in Patients with Prediabetes: Double-Blind, Placebo-Controlled, and Randomized Pilot Trial. BMC Endocrine Disorders, 23, Article No. 190.
https://doi.org/10.1186/s12902-023-01442-y
[21] Wang, L., Ge, H., Wei, G., Pong, L., Wu, L. and Ye, H. (2020) Berberine and Prediabetes: A Clinical Observational Study. Journal of Diabetes Mellitus, 10, 209-221.
https://doi.org/10.4236/jdm.2020.104017
[22] Ye, Y., Liu, X., Wu, N., Han, Y., Wang, J., Yu, Y., et al. (2021) Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Frontiers in Pharmacology, 12, Article 653887.
https://doi.org/10.3389/fphar.2021.653887
[23] Lian, F., Li, G., Chen, X., Wang, X., Piao, C., Wang, J., et al. (2014) Chinese Herbal Medicine Tianqi Reduces Progression from Impaired Glucose Tolerance to Diabetes: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism, 99, 648-655.
https://doi.org/10.1210/jc.2013-3276
[24] Ji, H., Zhao, X., Chen, X., et al. (2024) Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial. JAMA Internal Medicine, 184, 727-735.
[25] Jiang, L., Zhang, Y., Zhang, H., Chen, Y., Huang, W., Xiao, Y., et al. (2022) Comparative Efficacy of 6 Traditional Chinese Patent Medicines Combined with Lifestyle Modification in Patients with Prediabetes: A Network Meta-Analysis. Diabetes Research and Clinical Practice, 188, Article ID: 109878.
https://doi.org/10.1016/j.diabres.2022.109878
[26] Zhang, M., Wang, C.C. and Lo, J. (2022) Should Acupuncture-Related Therapies Be Considered in Prediabetes Control? Results from a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Holistic Nursing Practice, 36, 198-208.
https://doi.org/10.1097/hnp.0000000000000530
[27] Yu, Y., Xu, X., Tan, D., Yin, Y., Yang, X. and Yu, R. (2023) A Study on the Use of Acupoint Catgut Embedding in the Treatment of Pre-Diabetes: A Meta-Analysis and Data Mining Approach. Frontiers in Public Health, 11, Article 1282720.
https://doi.org/10.3389/fpubh.2023.1282720
[28] Li, S., Zhou, H., Zhou, M., Lou, L., Luo, L. and Ji, S. (2025) The Effects of Acupoint Catgut Embedding Therapy on Anthropometric Parameters and Endocrine Function in Obese Women: A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 12, Article 1583556.
https://doi.org/10.3389/fnut.2025.1583556
[29] Yue, J.H., Li, X.L., Zhang, Y., Yang, G., Mah, J.Z., Li, A., et al. (2024) Comparing Verum and Sham Acupoint Catgut Embedding for Adults with Obesity: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Medicine, 103, e36653.
https://doi.org/10.1097/md.0000000000036653
[30] Cho, S.H., Lee, J.S., Thabane, L. and Lee, J. (2009) Acupuncture for Obesity: A Systematic Review and Meta-Analysis. International Journal of Obesity, 33, 183-196.
https://doi.org/10.1038/ijo.2008.269
[31] Tuǧrul Cabıoǧlu, M. and Ergene, N. (2005) Electroacupuncture Therapy for Weight Loss Reduces Serum Total Cholesterol, Triglycerides, and LDL Cholesterol Levels in Obese Women. The American Journal of Chinese Medicine, 33, 525-533.
https://doi.org/10.1142/s0192415x05003132